Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Gait and six-minute walk performance in persons with multiple sclerosis.
[Therapy adherence to immunomodulator treatment in patients with multiple sclerosis].
The Cannabinoid Use in Progressive Inflammatory brain Disease (CUPID) trial: a randomised double-blind placebo-controlled parallel-group multicentre trial and economic evaluation of cannabinoids to slow progression in multiple sclerosis.
Cost-effectiveness of multiple sclerosis disease-modifying therapies: a systematic review of the literature.
MOG extracellular domain (p1-125) triggers elevated frequency of CXCR3+ CD4+ Th1 cells in the CNS of mice and induces greater incidence of severe EAE.
Something Old, New, Borrowed, Blue: Anthracenedione Agents for Treatment of Multiple Sclerosis.
The role of IL-2 in the activation and expansion of regulatory T-cells and the development of experimental autoimmune encephalomyelitis.
Optical coherence tomography shows retinal abnormalities associated with optic nerve disease.
Neuromyelitis optica in child: diagnostic and therapeutic challenges.
Acute disseminated encephalomyelitis following infectious mononucleosis in a toddler.
Brain atrophy at onset and physical disability in multiple sclerosis.
A systematic review and meta-analysis of strength training in individuals with multiple sclerosis or Parkinson disease.
TET2 gene expression and 5-hydroxymethylcytosine level in multiple sclerosis peripheral blood cells.
Assessment of blinding to treatment allocation in studies of a cannabis-based medicine (Sativex(R)) in people with multiple sclerosis: a new approach.
Repeatability of the timed 25-foot walk test for individuals with multiple sclerosis.
An exploratory study of decision making by informal caregivers of individuals with multiple sclerosis.
Danish translation and psychometric testing of the Rivermead Mobility Index.
A comparative optical coherence tomography study in neuromyelitis optica spectrum disorder and multiple sclerosis.
Expression of semaphorin 3A, semaphorin 7A and their receptors in multiple sclerosis lesions.
Management of faecal incontinence and constipation in adults with central neurological diseases.
IL-4/10 prevents stress vulnerability following imipramine discontinuation.
A case of neuromyelitis optica associated with anti-aquaporin 4 antibody and other autoantibodies.
Emerging tumefactive multiple sclerosis after switching therapy from natalizumab to fingolimod.
Influence of the use of statin on the stability of erythrocyte membranes in multiple sclerosis.
Acceptance of the Extracare Program by Beta Interferon-Treated Patients With Multiple Sclerosis: Results of the Explore Study.

Pages